This week’s reported global health innovation funding included:
Claris Biotherapeutics, a Jersey City, NJ-based biopharmaceutical company developing therapies for sight-threatening ocular surface diseases, raised $118M co-led by Samsara Biocapital and Catalio Capital Management, with participation from Adage Capital Management, Sofinnova Investments, Aisling Capital, ADAR1 Capital Management, Novo Holdings, Janus Henderson Investors, and Mass General Brigham Ventures. <source>
Bios Life, a Boston, MA-based AI-native predictive cancer surveillance and survivorship-care platform, raised $25M co-led by Redmile, Vsquared Ventures, and Kindred Capital, with participation from additional US and European healthcare and technology investors. <source>
HealthSnap, a Miami, FL-based AI-powered virtual care management platform, raised $25M led by Eastward Capital Partners. <source>
Salus Scientific, a Charleston, SC-based occupational wellness company building radiation-protection technology for physicians, technologists, and nurses performing fluoroscopy-guided procedures, raised $10.1M from undisclosed investors. <source>
Wellinks, a New Haven, CT-based cardiopulmonary virtual care platform, raised $10M in the first close of its round from UMass Memorial Health and inside investors. <source>
Longevium, a Dubai, UAE-based AI-powered longevity research and preventive-healthcare company, raised $7M from undisclosed investors. <source>
SkinBit, a Los Angeles, CA-based full-body skin-cancer screening and longitudinal skin-imaging data platform, raised $6M from Boost VC, Cleo Capital, Manna Ventures, and Profluent Capital, with participation from angel investors including Logan Green. <source>
Vexev, a Sydney, Australia-based medical robotics company automating vascular ultrasound imaging, raised A$8.6M (~$6M) from TreeArc Investment Group, TEN13, Bioshore Ventures, and Alumni Ventures, with participation from existing investors Blackbird Ventures, Neotribe Ventures, Startmate, and Horizon. <source>
Blaze.tech, a Los Angeles, CA-based AI app-building platform purpose-built for healthcare, raised $5M from Friale. <source>
Join StartUp Health
A global community for the bold decision makers, thought leaders, funders, and innovators transforming the future of health – this is where the global health ecosystem comes together to learn from experts, share insights, build relationships, explore partnerships, and shape what’s next in health.
👉 Join today, no application necessary
Meduloc, a West Chester, PA-based orthopedic device company developing a flexible fracture-fixation platform, raised $4M led by GenHenn Capital, with participation from Life Sciences Greenhouse Investments, Ben Franklin Technology Partners of Southeastern PA, Broad Street Angels, and Andre Ethier. <source>
Claryx, a New York, NY-based metagenomic sequencing platform that detects hospital pathogen outbreaks before they start, raised $3.5M led by Outlander, with participation from Company Ventures, Boost VC, Neon, Mana Ventures, 640 Oxford, and Precursor Ventures. <source>
RevealDx, a Seattle, WA-based AI platform for lung-nodule characterization, received a $3.4M strategic investment from 4DMedical tied to a distribution agreement. <source>
MiiHealth Ai, a Phoenix, AZ-based agentic AI medical-assistant platform that automates patient intake, raised $2.8M led by Russell Glass of Arteria Capital, with participation from physician angels, healthcare operators, and digital health founders. <source>
Consint.AI, a Noida, India-based AI platform for healthcare and insurance fraud, waste, and abuse detection, raised ₹22 crore (~$2.3M) from BIG Global Investment JSC, Equanimity Ventures, and Seafund. <source>
Relu, a Leuven, Belgium-based AI platform that automates design and administrative workflows for dental labs, raised $1.75M from Dental Innovation Alliance. <source>
Opal Therapeutics, a San Francisco, CA-based patient-derived organoid platform for women's gynecological health, received a $1.25M non-dilutive award from the National Science Foundation. <source>
Advanced eClinical Training, a New York, NY-based provider of healthcare workforce certification and training programs, received an undisclosed strategic investment from Tortuga Growth Partners. <source>
CND Life Sciences, a Scottsdale, AZ-based neurodiagnostics company behind the Syn-One Test for neurodegenerative diseases, raised undisclosed growth financing led by S-Curve Partners. <source>
Data is from StartUp Health Insights, the most comprehensive funding database for health innovation. Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox. Follow us on LinkedIn for daily updates on Health Moonshots.
